Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Libidus (September 14, 2006)
- Starting date:
- September 14, 2006
- Posting date:
- October 02, 2006
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-2006A197
Reason
Laboratory analysis conducted by Health Canada has determined that samples of Libidus lot# LIB06010 obtained from NorthRegentRx, Winnipeg, Manitoba and a Canadian retailer contain piperidino vardenafil as an undeclared ingredient.
Depth of distribution
Retailers and Individuals in Canada.
Affected products
Libidus
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Capsule
Strength
- Eurycoma Longifolia (154.0 mg)
- Flos Carthami (24.5 mg)
- Rhizoma Cucurmae Longae (49.0 mg)
- Herba Ginkgo Biloba Extract (49.0 mg)
- Herba Epimedii (24.5 mg)
- Herba Cistanches (24.5 mg)
- Astragalus Membranaceus (24.5 mg)
Lot or serial number
LIB06010, LIB06011
Companies
- Recalling Firm
- NorthRegentRx
P.O. Box 49082, RPO Garden City
Winnipeg Manitoba
Canada R2V 4G8
- Marketing Authorization Holder
- Not Applicable
- Date modified: